Literature DB >> 22497787

Toxin modulators and blockers of hERG K(+) channels.

J M Jiménez-Vargas1, R Restano-Cassulini, L D Possani.   

Abstract

The K(+) channel encoded by the Ether-á-go-go-Related Gene (ERG) is expressed in different tissues of different animal species. There are at least three subtypes of this channel, being the sub-type 1 (ERG1) crucial in the repolarization phase of the cardiac action potential. Mutations in this gene can affect the properties of the channel producing the type II long QT syndrome (LQTS2) and many drugs are also known to affect this channel with a similar side effect. Various scorpion, spider and sea anemone toxins affect the ERG currents by blocking the ion-conducting pore from the external side or by modulating channel gating through binding to the voltage-sensor domain. By doing so, these toxins become very useful tools for better understanding the structural and functional characteristics of these ion channels. This review discusses the interaction between the ERG channels and the peptides isolated from venoms of these animals. Special emphasis is placed on scorpion toxins, although the effects of several spider venom toxins and anemone toxins will be also revised.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22497787     DOI: 10.1016/j.toxicon.2012.03.024

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  10 in total

Review 1.  Scorpion venom components that affect ion-channels function.

Authors:  V Quintero-Hernández; J M Jiménez-Vargas; G B Gurrola; H H Valdivia; L D Possani
Journal:  Toxicon       Date:  2013-07-26       Impact factor: 3.033

2.  Marine algal toxin azaspiracid is an open-state blocker of hERG potassium channels.

Authors:  Michael J Twiner; Gregory J Doucette; Andrew Rasky; Xi-Ping Huang; Bryan L Roth; Michael C Sanguinetti
Journal:  Chem Res Toxicol       Date:  2012-08-10       Impact factor: 3.739

3.  hERG potassium channel blockage by scorpion toxin BmKKx2 enhances erythroid differentiation of human leukemia cells K562.

Authors:  Jian Ma; Youtian Hu; Mingxiong Guo; Zan Huang; Wenxin Li; Yingliang Wu
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

Review 4.  Antiviral activity of animal venom peptides and related compounds.

Authors:  Élida Cleyse Gomes da Mata; Caroline Barbosa Farias Mourão; Marisa Rangel; Elisabeth Ferroni Schwartz
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-01-06

5.  Australian Scorpion Hormurus waigiensis Venom Fractions Show Broad Bioactivity Through Modulation of Bio-Impedance and Cytosolic Calcium.

Authors:  David M Housley; Jeremy L Pinyon; Georg von Jonquieres; Chamini J Perera; Michael Smout; Michael J Liddell; Ernest A Jennings; David Wilson; Gary D Housley
Journal:  Biomolecules       Date:  2020-04-16

Review 6.  Scorpion Venom: Detriments and Benefits.

Authors:  Shirin Ahmadi; Julius M Knerr; Lídia Argemi; Karla C F Bordon; Manuela B Pucca; Felipe A Cerni; Eliane C Arantes; Figen Çalışkan; Andreas H Laustsen
Journal:  Biomedicines       Date:  2020-05-12

7.  Beyond hemostasis: a snake venom serine protease with potassium channel blocking and potential antitumor activities.

Authors:  Johara Boldrini-França; Ernesto Lopes Pinheiro-Junior; Steve Peigneur; Manuela Berto Pucca; Felipe Augusto Cerni; Rafael Junqueira Borges; Tássia Rafaella Costa; Sante Emmanuel Imai Carone; Marcos Roberto de Mattos Fontes; Suely Vilela Sampaio; Eliane Candiani Arantes; Jan Tytgat
Journal:  Sci Rep       Date:  2020-03-11       Impact factor: 4.379

Review 8.  The Challenges of Predicting Drug-Induced QTc Prolongation in Humans.

Authors:  Jean-Pierre Valentin; Peter Hoffmann; Catherine Ortemann-Renon; John Koerner; Jennifer Pierson; Gary Gintant; James Willard; Christine Garnett; Matthew Skinner; Hugo M Vargas; Todd Wisialowski; Michael K Pugsley
Journal:  Toxicol Sci       Date:  2022-04-26       Impact factor: 4.109

9.  Electrophysiological analysis of mammalian cells expressing hERG using automated 384-well-patch-clamp.

Authors:  Yuji Haraguchi; Atsushi Ohtsuki; Takayuki Oka; Tatsuya Shimizu
Journal:  BMC Pharmacol Toxicol       Date:  2015-12-16       Impact factor: 2.483

Review 10.  Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial Fibrillation.

Authors:  Jesús Borrego; Adam Feher; Norbert Jost; Gyorgy Panyi; Zoltan Varga; Ferenc Papp
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.